PortfoliosLab logo

Amicus Therapeutics, Inc.

FOLD
Equity · Currency in USD
Sector
Healthcare
Industry
Biotechnology
ISIN
US03152W1099
CUSIP
03152W109

FOLDPrice Chart


Chart placeholderClick Calculate to get results

FOLDPerformance

The chart shows the growth of $10,000 invested in Amicus Therapeutics, Inc. on Jan 5, 2010 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $27,344 for a total return of roughly 173.44%. All prices are adjusted for splits and dividends.


FOLD (Amicus Therapeutics, Inc.)
Benchmark (S&P 500)

FOLDReturns in periods

Returns over 1 year are annualized

PeriodReturn
1M-4.72%
6M6.38%
YTD-54.53%
1Y-40.48%
5Y7.05%
10Y11.79%

FOLDMonthly Returns Heatmap


Chart placeholderClick Calculate to get results

FOLDSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Amicus Therapeutics, Inc. Sharpe ratio is -0.74. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


FOLD (Amicus Therapeutics, Inc.)
Benchmark (S&P 500)

FOLDDividends


Amicus Therapeutics, Inc. doesn't pay dividends

FOLDDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


FOLD (Amicus Therapeutics, Inc.)
Benchmark (S&P 500)

FOLDWorst Drawdowns

The table below shows the maximum drawdowns of the Amicus Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Amicus Therapeutics, Inc. is 77.08%, recorded on Apr 16, 2014. It took 155 trading sessions for the portfolio to recover.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-77.08%Jun 7, 2011720Apr 16, 2014155Nov 25, 2014875
-75.15%Sep 16, 2015322Dec 22, 2016965Oct 23, 20201287
-65.01%Dec 23, 2020105May 25, 2021
-52.44%Jan 12, 2010122Jul 7, 201078Oct 26, 2010200
-26.28%Aug 6, 201513Aug 24, 201514Sep 14, 201527
-22.25%Jan 9, 201521Feb 9, 201521Mar 11, 201542
-19.26%Mar 20, 201529Apr 30, 201525Jun 5, 201554
-14.61%Nov 15, 201017Dec 8, 20109Dec 21, 201026
-14.24%Jan 19, 20118Jan 28, 20119Feb 10, 201117
-14.23%May 4, 20117May 12, 20118May 24, 201115

FOLDVolatility Chart

Current Amicus Therapeutics, Inc. volatility is 33.79%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


FOLD (Amicus Therapeutics, Inc.)
Benchmark (S&P 500)

Portfolios with Amicus Therapeutics, Inc.


Loading data...

More Tools for Amicus Therapeutics, Inc.